top of page

Optimizing and

accelerating clinical trial outcomes by leveraging ML and predictive analysis

About Us

We are a young, enthusiastic company that aims to change the way clinical trials are designed and performed, transforming drug development and production and ultimately improving the health and quality of life.

Solution

Panacea-ml delivers high-value insights that enable pharmaceutical companies and CROs to design and perform clinical trials that can bring effective treatments to market faster

Pharma

add_edited.png
add_edited.png
add_edited.png
add_edited.png

Minimize the risk of trial failure.

Reduce trial duration.

Reduce trial cost.

 

Maximize the chances for market approval.

freepik__background__15637.png

CRO

add_edited.png
add_edited.png
add_edited.png
add_edited.png

​Advantage over competition.

Reduce operational costs.​

Increase recruitment rates.

Reduce dropout.

freepik__background__60574.png

Product

Our SaaS AI system has a user-friendly interface customized to the client and is agnostic to both the disease and the treatment. Currently, we validate our products in diseases including ALS, diabetes, and cancer, among others.

Mission

We leverage clinical development data analytics to streamline clinical trials, providing drug developers and CROs with a competitive edge.  Panacea-ml's analysis of historical patient data identifies which trial participants could most benefit from a drug and which might develop adverse side effects, increasing the chances of a successful trial and improving patient care and outcomes.
Panacea-ml produces valuable insights, which help our clients make informed decisions.

Naomi Fried headshot brwn cropped_edited_edited.jpg

Naomi Fried, Ph.D 
PharmStars CEO

 I endorse Panacea-ml's innovative explainable-AI technology for revolutionizing trial design, improving insights into failed trials, and enforcing the probability of success in clinical programs.

Julian Isla_edited_edited.jpg

Julian Isla
Microsoft Data and AI Manager

EMA COMP Member

I'm impressed by Panacea-ml's use of advanced analytics and explainable-AI to optimize patient selection and enhance trial outcomes with unique insights. Their approach makes trials more efficient and patient-centric.

image001 (1)_edited_edited_edited_edited.jpg

Ed Saltzman
Lumanity Senior Strategic Advisor

I believe Panacea-ml's innovative technology will reduce clinical trial attrition, accelerating patient access to treatments, while maximizing return from clinical development spend.

Our Partners

Shaar_edited.jpg

Publications & News

Meet the team

raphael 1_edited.jpg

Raphael Giami

LinkedIn

CEO

X
_DSC9049_edited_edited_edited.jpg

Prof. Boaz Lerner

LinkedIn

Founder & CSO

X
_DSC9039_edited_edited_edited_edited.jpg

Shay Chaim

LinkedIn

VP R&D

X
_DSC8982_edited_edited_edited.jpg

Anat Ohar

LinkedIn

Marketing & Operations

X
_DSC9044_edited_edited_edited.jpg

Roy Wolf

LinkedIn

Data scientist & AI Eng.

X

Advisory Board

image002_edited_edited_edited.jpg

Alexandre Lebeaut, M.D

LinkedIn

Advisor Pharma R&D

X
Naomi Fried headshot brwn cropped_edited

Naomi Fried, Ph.D

LinkedIn

Advisor Pharma Partnership

X
Michel Abitboul_edited_edited_edited_edi

Michel Abiteboul, M.D

LinkedIn

Advisor CRO Engagement

X
Julian Isla_edited_edited_edited.jpg

Julian Isla

LinkedIn

Advisor AI Enterprise solution 

X
image001 (1)_edited_edited_edited_edited

Ed Saltzman

LinkedIn

Advisor Biotech Partnership

X

Board of Directors

תמונה אסף (003)_edited_edited_edited_edi

Asaf Barnea

LinkedIn

Chairman of the Board

X
ערן_edited_edited_edited.jpg

Eran Toledo, Ph.D

LinkedIn

Board Member

X
Gal-299 (002)_edited_edited.jpg

Gal Salomon

LinkedIn

Board Member

X
_DSC9049_edited_edited_edited.jpg

Prof. Boaz Lerner

LinkedIn

Board Member

X

Backed by

IIA_LOGO_P שקוףNG_BLUE_31.png
Sanara-Logo1.png
teva.jpg
BGU logo (002).jpg

Thanks for submitting!

Get in Touch!

Zarhin 13 street,

Ra'anana, Israel

  • LinkedIn
  • crunchbaser_edited
  • Dealroom logo_edited
  • f6s-logo-bw
bottom of page